【石純宇】評論

(B)目前無C型肝炎疫苗，因為相較A、B型肝炎病毒，突變率高，對甲有效，傳給乙後突變則無效

【1m】評論

(a)The main strategy for reducing the risk of vertical HCV transmission is identifying and treating HCV-infected women prior to conception. The safety and efficacy of direct-acting antiviral agents during pregnancy and in neonates have not yet been assessed, and these agents should not be used in such populations. The treatment of HCV in children is discussed in detail elsewhere.Children <12 years — For virtually all children younger than 12 years of age with HCV infection, we suggest deferring treatment until an all-oral DAA regimen is available (algorithm 1) . These individuals may becom...